Literature DB >> 14526194

Posterior lumbar interbody fusion for degenerative disc disease using a minimally invasive B-twin expandable spinal spacer: a multicenter study.

Yoram Folman1, Sang-Ho Lee, Jose Raul Silvera, Reuven Gepstein.   

Abstract

Acquired degenerative disc disease causes gradual disc space collapse, concurrent discogenic or facet-induced pain, and possible compression radiculopathy. Surgical treatment aims to re-expand the intervertebral space and stabilize the involved segment in balanced alignment until fusion is complete. The prevailing methods make use of a twin cage device of predetermined size. Their implantation requires extensive exposure, entailing the sacrifice of posterior stabilizing structures. The procedure also results in significant traction on the dural sac and the cauda equina and is thereby a potential source of neurologic damage. The new expandable spinal spacer (ESS) was designed to mitigate all the shortcomings alluded to above. A prospective multicenter clinical study was conducted of 87 patients with chronic low back pain due to degenerative disc disease, treated by posterior lumbar interbody fusion (PLIF) using a newly designed ESS. The study protocol was approved by the ethics committees of all the participating institutions. The objective was to test the safety and efficacy of the device. Each participant was followed periodically for >1 postoperative year. The ongoing record included intraoperative difficulties and complications, if any, radiologic evidence of fusion and clinical outcome as scored by pre- and postoperative questionnaires pertaining to pain intensity and degree of disability. No dural lacerations or neurologic deficit occurred. There were no mechanical failures of the spacer. Radiologic study demonstrated fusion in all but one patient. Disc space height that averaged 7.53 +/- 2.42 mm before surgery increased to 10.03 +/- 2.00 mm at the time of surgery and stabilized at 9.47 +/- 2.10 mm upon final follow-up. Visual Analog Scale and Oswestry Index decreased by 60% and 58%, respectively. PLIF using the ESS achieves the same ultimate outcome as do other methods currently in use but does not share the handicaps and hazards and is more user-friendly to the surgeon.

Entities:  

Mesh:

Year:  2003        PMID: 14526194     DOI: 10.1097/00024720-200310000-00004

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  8 in total

1.  Biomechanical effects of an oblique lumbar interbody fusion combined with posterior augmentation: a finite element analysis.

Authors:  Shengjia Huang; Shaoxiong Min; Suwei Wang; Anmin Jin
Journal:  BMC Musculoskelet Disord       Date:  2022-06-27       Impact factor: 2.562

2.  Comparative Effectiveness of Expandable Versus Static Interbody Spacers via MIS LLIF: A 2-Year Radiographic and Clinical Outcomes Study.

Authors:  Yan Michael Li; Richard F Frisch; Zheng Huang; James Towner; Yan Icy Li; Samantha L Greeley; Charles Ledonio
Journal:  Global Spine J       Date:  2019-10-29

Review 3.  Biomaterials for Interbody Fusion in Bone Tissue Engineering.

Authors:  Han Zhang; Zhonghan Wang; Yang Wang; Zuhao Li; Bo Chao; Shixian Liu; Wangwang Luo; Jianhang Jiao; Minfei Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-17

4.  Posterolateral versus circumferential instrumented fusion for monosegmental lumbar degenerative disc disease using an expandable cage.

Authors:  Panagiotis Korovessis; Thomas Repantis; Andreas Baikousis; Panagiotis Iliopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-10-21

5.  Percutaneous posterior-lateral lumbar interbody fusion for degenerative disc disease using a B-Twin expandable spinal spacer.

Authors:  Lizu Xiao; Donglin Xiong; Qiang Zhang; Jin Jian; Husan Zheng; Yuhui Luo; Juanli Dai; Deren Zhang
Journal:  Eur Spine J       Date:  2009-09-26       Impact factor: 3.134

6.  Percutaneous Transforaminal Endoscopic Lumbar Interbody Fusion: Clinical and Radiological Results of Mean 46-Month Follow-Up.

Authors:  Sang-Ho Lee; H Yener Erken; Junseok Bae
Journal:  Biomed Res Int       Date:  2017-02-27       Impact factor: 3.411

7.  Percutaneous Endoscopic Lumbar Interbody Fusion: Technical Note and Preliminary Clinical Experience with 2-Year Follow-Up.

Authors:  Junlong Wu; Huan Liu; Shengxiang Ao; Wenjie Zheng; Changqing Li; Haiyin Li; Yong Pan; Chao Zhang; Yue Zhou
Journal:  Biomed Res Int       Date:  2018-11-19       Impact factor: 3.411

8.  Comparison of percutaneous endoscopic and open posterior lumbar interbody fusion for the treatment of single-segmental lumbar degenerative diseases.

Authors:  Li-Ming He; Kuo-Tai Chen; Chien-Min Chen; Qiang Chang; Lin Sun; Yan-Nan Zhang; Jian-Jun Chang; Hao-Yu Feng
Journal:  BMC Musculoskelet Disord       Date:  2022-04-07       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.